Showing results (251-260 of 599) with videos related to
Sort By:
Pageof 60
Diabetes Technology & Therapeutics|March 21, 2024
Continuous Glucose Monitoring-Derived Glucometrics in Adults with Type 1 Diabetes When Switching Basal InsulinsRobbe De Groote, Eveline Lefever, Sara Charleer, et al.Diabetes, Obesity & Metabolism|July 6, 2022
Predictors of time in target glucose range in real-world users of the MiniMed 780G systemJavier Castañeda, Chantal Mathieu, Henk-Jan Aanstoot, et al.Implementation Science : IS|July 24, 2009
Barriers and facilitators to evidence based care of type 2 diabetes patients: experiences of general practitioners participating to a quality improvement programGeert Goderis, Liesbeth Borgermans, Chantal Mathieu, et al.Nutrients|October 14, 2018
Screening and Management of Gestational Diabetes Mellitus after Bariatric SurgeryKatrien Benhalima, Caro Minschart, Dries Ceulemans, et al.The Journal of Urology|January 26, 2010
Crucial role of interferon-gamma in experimental autoimmune prostatitisRuben Darío Motrich, Evelyne van Etten, Femke Baeke, et al.Expert Opinion on Therapeutic Targets|April 26, 2021
Targeting citrullination in autoimmunity: insights learned from preclinical mouse modelsYlke Bruggeman, Fernanda M C Sodré, Mijke Buitinga, et al.Diabetology & Metabolic Syndrome|January 11, 2014
Screening for pregestational and gestational diabetes in pregnancy: a survey of obstetrical centers in the northern part of BelgiumKatrien Benhalima, Paul Van Crombrugge, Roland Devlieger, et al.Diabetes Care|November 6, 2025
Toward Disease-Modifying Therapies in Type 1 Diabetes: Focus on TeplizumabChantal Mathieu, Emily K Sims, Lucienne Chatenoud, et al.Diabetes Care|August 11, 2016
Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized TrialChantal Mathieu, Bernard Zinman, Joanna Uddén Hemmingsson, et al.Plos One|February 2, 2011
Traffic air pollution and oxidized LDLLotte Jacobs, Jan Emmerechts, Marc F Hoylaerts, et al.Pageof 60